For approval, read the drug record
The drug agency’s name is Food and Drug Administration; FDA is its short form.
Its records showed the old Geref products as discontinued in September 2026, with no marketed FDA-approved sermorelin product.
The federal notice on Geref also explains why its withdrawal was not for reasons of safety or effectiveness.
Ask for the date behind any claim about present approval. Then ask whether that claim describes the exact product in the offer.
For a promised result, read what was measured
The linked adult studies were small and short; some tested sermorelin, while another tested a medicine made by changing part of it.
A study abstract is a brief account of the research. Ask whoever provides your care to describe the people studied, the comparisons made and the changes found.
Does the source measure the benefit named in the offer?
For a name, use the board’s record
Public doctor records held by medical boards show licences and recorded action against a doctor; pharmacy board records show pharmacy licences.
Keep the care service’s name apart from the name of whoever will treat you. Ask which state board has the licence record for that person’s role.
Open the source notes
Choose a record to read the source behind a claim.
- Approval record — sermorelin applications
- Geref withdrawal — the federal finding
- Pharmacy-made medicines — the ingredient rule
- Adult research — hormone and body-composition results
- Adult research — a medicine similar to sermorelin
- Doctor check — find the medical board
- Pharmacy check — find the state licence search